Pier Capital LLC grew its holdings in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) by 23.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 511,798 shares of the company's stock after purchasing an additional 97,256 shares during the period. Pier Capital LLC owned approximately 1.33% of Quanterix worth $6,633,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of QTRX. Price T Rowe Associates Inc. MD increased its holdings in shares of Quanterix by 3.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 39,916 shares of the company's stock valued at $941,000 after purchasing an additional 1,186 shares during the period. Comerica Bank grew its holdings in Quanterix by 44,205.6% during the first quarter. Comerica Bank now owns 7,975 shares of the company's stock worth $188,000 after acquiring an additional 7,957 shares during the period. Assenagon Asset Management S.A. acquired a new position in Quanterix during the second quarter worth about $3,389,000. Baillie Gifford & Co. grew its holdings in Quanterix by 1.6% during the second quarter. Baillie Gifford & Co. now owns 633,460 shares of the company's stock worth $8,368,000 after acquiring an additional 10,105 shares during the period. Finally, Easterly Investment Partners LLC grew its holdings in Quanterix by 779.9% during the second quarter. Easterly Investment Partners LLC now owns 692,746 shares of the company's stock worth $9,151,000 after acquiring an additional 614,012 shares during the period. 86.48% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research analysts recently issued reports on QTRX shares. TD Cowen lifted their target price on Quanterix from $13.50 to $16.00 and gave the stock a "hold" rating in a report on Wednesday, November 13th. Scotiabank lowered their target price on Quanterix from $32.00 to $28.00 and set a "sector outperform" rating on the stock in a report on Monday, August 12th.
Check Out Our Latest Stock Report on Quanterix
Quanterix Stock Performance
QTRX traded up $0.30 during trading on Friday, reaching $11.97. The company had a trading volume of 214,426 shares, compared to its average volume of 409,171. The firm's 50-day simple moving average is $12.57 and its 200 day simple moving average is $13.40. The company has a market cap of $459.40 million, a price-to-earnings ratio of -11.40 and a beta of 1.30. Quanterix Co. has a 12-month low of $10.50 and a 12-month high of $29.70.
About Quanterix
(
Free Report)
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
See Also
Before you consider Quanterix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quanterix wasn't on the list.
While Quanterix currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.